<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ - 文字轨迹</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/2025-05/eco_2025%E4%B8%A8select_%E7%A0%94%E7%A9%B6%E8%8E%B7%E7%9B%8A%E6%96%B0%E8%AF%81%E6%8D%AE_%E5%8F%B8%E7%BE%8E%E6%A0%BC%E9%B2%81%E8%82%BD_%E5%87%8F%E9%87%8D%E7%89%88_%E8%83%BD%E5%90%A6%E8%AE%A9%E6%82%A3%E8%80%85%E8%B5%A2%E5%9C%A8%E8%B5%B7%E8%B7%91%E7%BA%BF_/"><meta property="og:site_name" content="文字轨迹"><meta property="og:title" content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？"><meta property="og:description" content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ by 丁香园 导语"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-05-31T11:23:50+00:00"><meta property="article:modified_time" content="2025-05-31T11:23:50+00:00"><meta property="article:tag" content="Fetched"><meta property="article:tag" content="丁香园"><meta itemprop=name content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？"><meta itemprop=description content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ by 丁香园 导语"><meta itemprop=datePublished content="2025-05-31T11:23:50+00:00"><meta itemprop=dateModified content="2025-05-31T11:23:50+00:00"><meta itemprop=wordCount content="314"><meta itemprop=keywords content="Fetched,丁香园"><meta name=twitter:card content="summary"><meta name=twitter:title content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？"><meta name=twitter:description content="ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ by 丁香园 导语"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=文字轨迹 rel=home><div class="logo__item logo__text"><div class=logo__title>文字轨迹</div><div class=logo__tagline>故事流淌过的地方</div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>文章</span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>标签</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>关于</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-05-31T11:23:50Z>2025-05-31</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/duty/ rel=category>Duty</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#eco-2025丨select-研究获益新证据司美格鲁肽减重版能否让患者赢在起跑线-by-丁香园>ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ by 丁香园</a></li></ul></nav></div></div><div class="content post__content clearfix"><h2 id=eco-2025丨select-研究获益新证据司美格鲁肽减重版能否让患者赢在起跑线-by-丁香园>ECO 2025丨SELECT 研究获益新证据：司美格鲁肽（减重版）能否让患者赢在起跑线？ by 丁香园</h2><div><section data-pm-slice="0 0 []"><section><p><strong><span leaf>导语</span></strong></p></section><p><span leaf><br></span></p><p><span leaf>近日，中国国家药品监督管理局（NMPA）批准更新司美格鲁肽（减重版）(商品名诺和盈</span><sup><span leaf>®</span></sup><span leaf>）的说明书，增加</span><span><strong><span leaf>在超重或肥胖且已确诊心血管疾病不伴有糖尿病的成人患者中，司美格鲁肽（减重版）可降低主要不良心血管事件（MACE）发生风险</span></strong></span><sup><span leaf>[1]</span></sup><span leaf>。在长期安全有效减重的基础上，此次说明书更新为司美格鲁肽（减重版）的显著心血管获益再添有力的临床证据。</span></p><p><span leaf><br></span></p><section><p><span leaf>2025 年 5 月 11～14 日，第 32 届欧洲肥胖大会（ECO 2025）在西班牙马拉加隆重召开。本次 ECO 2025 大会公布了一项重要研究——「Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease：A Secondary Analysis of the SELECT Trial（司美格鲁肽[减重版]在超重或肥胖和心血管疾病成人中的早期临床获益：SELECT 试验的二次分析）」，研究再次揭示了使用司美格鲁肽（减重版）在心血管保护方面的早期获益</span><sup><span leaf>[2]</span></sup><span leaf>。本文将结合肥胖症与心血管疾病的关系，对该研究重点内容进行解读，以供读者参考。</span></p><p><span leaf><br></span></p><p><span leaf><br></span></p></section><section><p><strong><span leaf>肥胖拉响「警报」：带来心血管疾病风险，增加心血管负担</span></strong></p></section><section><p><span leaf><br></span></p><p><span leaf>肥胖症是一种复杂的、病程逐渐进展的慢性疾病，可通过直接作用和间接作用加速心血管疾病的发生（图 1）</span><sup><span leaf>[3,4]</span></sup><span leaf>。此外有研究显示，心血管疾病（CVD）是肥胖症患者最常见的死亡原因</span><sup><span leaf>[4]</span></sup><span leaf>。</span></p><p><span leaf><br></span></p></section><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVmFfTs25icoZEJ8U9QicOIEuIbA5WksJK2fbKl3ticVxMfGNibwrtb9wRJg/640?wx_fmt=png&amp;from=appmsg" data-ratio=1.1511470985155197 data-s=300,640 data-type=png data-w=741 data-imgfileid=506122058 src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVmFfTs25icoZEJ8U9QicOIEuIbA5WksJK2fbKl3ticVxMfGNibwrtb9wRJg/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><span leaf>图 1 肥胖对心血管系统的影响</span><sup><span leaf>[3]</span></sup></span></p><p><span leaf><br></span></p></section><section><section><p><span><strong><span leaf>一方面，超重/肥胖可显著增加心血管疾病风险。</span></strong></span><span leaf>一项纳入近 20 万例患者的大型研究显示，与体重指数（BMI）正常的人群相比，超重的成年男性和女性患心血管疾病的终生风险分别增加 </span><span><strong><span leaf>21% 和 32%</span></strong></span><span leaf>，肥胖的成年男性和女性风险增加更为明显，分别为 </span><span><strong><span leaf>67% 和 85%</span></strong></span><sup><span leaf>[5]</span></sup><span leaf>。</span></p><p><span leaf> </span></p><p><strong><span><span leaf>另一方面，超重/肥胖还可增加心血管事件负担。</span></span></strong><span leaf>肥胖不仅可促进血脂异常、2 型糖尿病和高血压等心血管危险因素的发生，也可独立于上述心血管危险因素，对心脏结构和功能有直接的不利影响，导致心血管疾病的发展，包括动脉粥样硬化、心力衰竭、心律失常等，造成心血管意外风险显著增加</span><sup><span leaf>[6,7]</span></sup><span leaf>。</span></p></section></section><section><p><span leaf><br></span></p><p><span leaf>因此，2024 年欧洲心脏病协会（ESC）发布的《肥胖与心血管疾病：ESC 临床共识声明》（以下简称「ESC 共识」）建议保持稳定健康的 BMI（20～25 kg/m</span><sup><span leaf>2</span></sup><span leaf>）和腰围（男性 &lt; 94 cm，女性 &lt; 80 cm），以降低血压和心血管疾病风险（Ⅰ 类推荐，证据等级 A）</span><sup><span leaf>[3]</span></sup><span leaf>。</span></p><p><span leaf><br></span></p><p><span leaf><br></span></p></section><section><p><strong><span leaf>SELECT 研究：证实司美格鲁肽（减重版）的心血管保护作用</span></strong></p></section><section><p><span leaf><br></span></p><p><span leaf>对于超重/肥胖患者，减重治疗是降低心血管事件的有效干预措施</span><sup><span leaf>[3,7]</span></sup><span leaf>。ESC 共识指出，</span><span><strong><span leaf>对于无糖尿病但存在超重（BMI > 27 kg/m</span><sup><span leaf>2</span></sup><span leaf>）或肥胖的慢性冠心病患者，建议考虑使用胰高血糖素样肽-1 受体激动剂（GLP-1RA）司美格鲁肽（减重版），以降低心血管死亡、心肌梗死或卒中的风险（Ila 类推荐，证据等级 B）</span></strong></span><sup><span leaf>[3]</span></sup><span leaf>。</span></p><p><span leaf><br></span></p><p><span leaf>SELECT 研究是一项具有里程碑意义的临床试验，它为 GLP-1RA 周制剂司美格鲁肽（减重版）的心血管保护作用提供了强有力的证据</span><sup><span leaf>[1]</span></sup><span leaf>。SELECT 研究纳入 17,604 例年龄 ≥ 45 岁，BMI ≥ 27 kg/m</span><sup><span leaf>2</span></sup><span leaf>，合并心血管疾病（既往心肌梗死、既往卒中或有症状的外周动脉疾病），且无糖尿病病史的超重或肥胖患者，在标准治疗基础上，随机接受司美格鲁肽 （减重版）或安慰剂治疗。平均随访 39.8 个月结果显示，与安慰剂组相比，</span><strong><span><span leaf>司美格鲁肽（减重版）组 MACE 风险下降达 20%</span></span></strong><span leaf>（HR 0.80，95% CI 0.72～0.90，</span><em><span leaf>P</span></em><span leaf> &lt; 0.001）（图 2）。安全性方面，司美格鲁肽（减重版）组严重不良事件（SAE）发生率显著低于安慰剂组（33.4% vs 36.4%，</span><em><span leaf>P</span></em><span leaf> &lt; 0.001），长期安全性和耐受性良好。 </span></p><p><span leaf><br></span></p></section><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVolPxs1e5W7fKictaG441yYpVgMvAvJLic7GFiaPiaUR1ukxt9wxCJnwvRg/640?wx_fmt=png&amp;from=appmsg" data-ratio=0.6064814814814815 data-s=300,640 data-type=png data-w=1080 data-imgfileid=506122061 src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVolPxs1e5W7fKictaG441yYpVgMvAvJLic7GFiaPiaUR1ukxt9wxCJnwvRg/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><span leaf>图 2 SELECT 研究：MACE 发生情况</span><sup><span leaf>[1]</span></sup></span></p><p><span leaf><br></span></p><p><span leaf><br></span></p></section><section><p><strong><span leaf>SELECT 研究二次分析：司美格鲁肽（减重版）具有早期临床获益</span></strong></p></section><section><p><span leaf><br></span></p><p><span leaf>本次 ECO 2025 大会上公布的研究，对 SELECT 研究二次分析考察了 MACE 获益的起始时间以及随机化后早期阶段的其他相关参数变化，旨在评估司美格鲁肽（减重版）在超重或肥胖合并心血管疾病成人患者中的早期临床获益，结果显示</span><sup><span leaf>[2]</span></sup><span leaf>：</span></p><p><span leaf><br></span></p></section><section><section><section><section><svg viewbox="0 0 1 1"/></section></section></section><section><section><p><span leaf>在随机分组后的 6 个月治疗期，与安慰剂组相比，</span><span><strong><span leaf>司美格鲁肽（减重版）组 MACE 风险降低 41%</span></strong></span><span leaf>（HR 0.59，95% CI 0.44～0.80），心血管死亡风险降低 53%（HR 0.47，95% CI 0.24～0.86)，非致死性心梗风险降低 43%（HR 0.57，95% CI 0.37～0.86)；随机分组后</span><span><strong><span leaf>短时间内，司美格鲁肽（减重版）即降低了 MACE 风险</span></strong></span><span leaf>（图 3）。</span></p></section></section></section><p><span leaf><br></span></p><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVpHN1aOicKG4L723aH0UWDxSxhXmTJVqiaTgxfTcpwkvtxRUKhwnmI4gg/640?wx_fmt=png&amp;from=appmsg" data-ratio=0.44907407407407407 data-s=300,640 data-type=png data-w=1080 data-imgfileid=506122062 src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVpHN1aOicKG4L723aH0UWDxSxhXmTJVqiaTgxfTcpwkvtxRUKhwnmI4gg/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><span leaf>图 3 SELECT 研究二次分析：MACE 风险每日风险比（HR）</span><sup><span leaf>[2]</span></sup></span></p><p><span leaf><br></span></p></section><section><section><section><section><svg viewbox="0 0 1 1"/></section></section></section><section><section><p><span leaf>随机分组后，</span><span><strong><span leaf>发生首次 MACE 的时间累积发生率曲线即显示出治疗组的早期分离，且治疗早期 MACE 降低先于被认为有临床意义的体重变化</span></strong></span><span leaf>（图 4、5）。此外，该研究未来还将根据 MACE 各组分、其他临床结局、患者亚组和随机化后早期阶段发生变化的其他参数等，对司美格鲁肽（减重版）与安慰剂的早期 MACE 分离情况进行分析。</span></p></section></section></section><p><span leaf><br></span></p><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSV1YCVOpLvBd9OY3NyfbYGtFLLMfXwcQeZXp7y5uMkqtgs2o6iczg0w0A/640?wx_fmt=png&amp;from=appmsg" data-ratio=0.3685185185185185 data-s=300,640 data-type=png data-w=1080 data-imgfileid=506122059 src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSV1YCVOpLvBd9OY3NyfbYGtFLLMfXwcQeZXp7y5uMkqtgs2o6iczg0w0A/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><span leaf>图 4 SELECT 研究二次分析：发生首次 MACE 的时间累积发生率曲线变化</span><sup><span leaf>[2]</span></sup></span></p><p><span leaf><br></span></p></section><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVXKpUvialBcIOSExEdmSfTRBAic4LRstY9q1kKsrm4z03NjhcIxJQl8sg/640?wx_fmt=png&amp;from=appmsg" data-ratio=0.35185185185185186 data-s=300,640 data-type=png data-w=1080 data-imgfileid=506122060 src="https://mmbiz.qpic.cn/mmbiz_png/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVXKpUvialBcIOSExEdmSfTRBAic4LRstY9q1kKsrm4z03NjhcIxJQl8sg/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><span leaf>图 5 SELECT 研究二次分析：发生首次 MACE 的时间和体重变化：HR 和估计治疗差异（ETD）随时间的变化</span><sup><span leaf>[2]</span></sup></span></p><p><span leaf><br></span></p><p><span leaf><br></span></p></section><section><p><strong><span leaf>小结</span></strong></p></section><p><span leaf><br></span></p><p><span leaf>肥胖症可显著增加心血管疾病风险及心血管事件负担。SELECT 研究证实了司美格鲁肽（减重版）的心血管保护作用，ECO 2025 大会上发布的 SELECT 研究二次分析进一步揭示了司美格鲁肽（减重版）的早期临床获益，为肥胖患者的心血管保护提供了更全面的循证依据。相信随着司美格鲁肽心血管适应证的获批，它将为此类患者带来更多的希望和福音。</span></p><p><span leaf><br></span></p><section><p><span leaf>本内容由诺和诺德提供支持</span></p><p><span leaf><br></span></p><p><span leaf>内容策划：梁家敏</span><span leaf><br></span><span leaf>内容审核：刘明丽</span></p><p><span leaf>题图来源：图虫创意</span></p></section><p><span leaf><br></span></p><section><section><section><section><p><span leaf>参考文献：</span></p><p><span leaf>[1]. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med, 2023, 389(24):2221-2232.</span></p><p><span leaf>[2]. Plutzky J, et al. Presented at ECO 2025, Malaga, Spain, 11–14 May 2025.</span></p><p><span leaf>[3]. Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2025;32(3):184-220.</span></p><p><span leaf>[4]. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984-e1010.</span></p><p><span leaf>[5]. Khan SS, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018 Apr 1;3(4):280-287.</span></p><p><span leaf>[6]. Obesity and cardiovascular disease: an ESC clinical consensus statement. European Heart Journal (2024) 45, 4063-4098.</span></p><p><span leaf>[7]. 国家卫生健康委办公厅关于印发肥胖症诊疗指南（2024年版）的通知. https://www.gov.cn/zhengce/zhengceku/202410/content_6981734.htm</span></p></section></section></section></section><p><span leaf><br></span></p><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVEHWaLjNCicY0uFMNY9CADibqENeDoLaoe8RaicMQxdBDWmbNLliaORycsA/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio=0.38425925925925924 data-s=300,640 data-type=jpeg data-w=1080 data-imgfileid=506122063 src="https://mmbiz.qpic.cn/mmbiz_jpg/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVEHWaLjNCicY0uFMNY9CADibqENeDoLaoe8RaicMQxdBDWmbNLliaORycsA/640?wx_fmt=jpeg&amp;from=appmsg"></section></section><p><span leaf><br></span></p><section><section><section><section nodeleaf><img data-src="https://mmbiz.qpic.cn/mmbiz_gif/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVAeHTG0x4mj0Yw59ibgicF7lj5KxFBHVtkBZmpibgeEmOf7nqHMpKGSLSQ/640?wx_fmt=gif&amp;from=appmsg" data-ratio=0.696 data-s=300,640 data-type=gif data-w=500 data-imgfileid=506122064 src="https://mmbiz.qpic.cn/mmbiz_gif/NzKkzoeG5s1hsU6uLgXCqQY1x1euYoSVAeHTG0x4mj0Yw59ibgicF7lj5KxFBHVtkBZmpibgeEmOf7nqHMpKGSLSQ/640?wx_fmt=gif&amp;from=appmsg"></section></section></section><section><section><section><p><span leaf>点击</span><span><strong><span leaf>「阅读原文」</span></strong></span><span leaf>，即可秒达「减重新视界」专区～</span></p></section></section></section></section></section><p><mp-style-type data-value=10000></mp-style-type></p></div><hr><a href=https://mp.weixin.qq.com/s/3gUnACFm_7u1m-Au8gyvrg ,target=_blank rel="noopener noreferrer">原文链接</a></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/fetched/ rel=tag>fetched</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/%E4%B8%81%E9%A6%99%E5%9B%AD/ rel=tag>丁香园</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/2025-05/%E7%BE%8E%E5%9B%A2%E5%A5%87%E8%A2%AD618/ rel=prev><span class=pager__subtitle>«&#8201;Previous</span><p class=pager__title>美团奇袭618</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/2025-06/%E4%B8%BA%E4%BB%80%E4%B9%88%E4%B8%80%E5%A4%9C%E4%B9%8B%E9%97%B4_%E6%89%80%E6%9C%89%E9%85%92%E5%BA%97%E9%83%BD%E6%8A%A2%E7%9D%80%E5%8D%96%E6%9E%95%E5%A4%B4_/ rel=next><span class=pager__subtitle>Next&#8201;»</span><p class=pager__title>为什么一夜之间，所有酒店都抢着卖枕头？</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Search… name=q aria-label=Search…>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/2025-12/%E5%90%8E%E6%B5%AA%E5%8D%B7%E6%AD%BB%E5%89%8D%E6%B5%AA__%E8%B0%B7%E6%AD%8C%E9%93%BE_%E5%B9%B4%E5%86%85%E6%B6%A8%E5%B9%85%E5%B7%B2%E5%BF%AB%E6%8E%A5%E8%BF%91_openai%E9%93%BE_%E7%9A%84%E4%B8%A4%E5%80%8D/>后浪卷死前浪？“谷歌链”年内涨幅已快接近“OpenAI链”的两倍</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-12/%E6%88%AA%E8%83%A1%E5%A5%88%E9%A3%9E_%E6%B4%BE%E6%8B%89%E8%92%99%E5%90%91%E5%8D%8E%E7%BA%B3%E5%85%84%E5%BC%9F%E5%8F%91%E8%B5%B7%E6%95%8C%E6%84%8F%E6%94%B6%E8%B4%AD%E8%A6%81%E7%BA%A6/>截胡奈飞？派拉蒙向华纳兄弟发起敌意收购要约</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-12/%E5%8F%B0%E7%A7%AF%E7%94%B5%E4%B9%B0%E8%B5%B0euv%E5%85%89%E5%88%BB%E6%9C%BA10%E5%B9%B4%E6%9D%A5%E4%B8%80%E5%8D%8A%E4%BA%A7%E9%87%8F/>台积电买走EUV光刻机10年来一半产量</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-12/%E8%BF%99%E4%B8%AA%E6%94%BF%E7%AD%96%E7%9C%9F%E7%9A%84%E9%9C%87%E6%83%8A%E5%88%B0%E6%88%91%E4%BA%86_/>这个政策真的震惊到我了！</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-12/%E7%BD%91%E9%A3%9E%E5%AE%98%E5%AE%A3827%E4%BA%BF%E7%BE%8E%E5%85%83%E6%94%B6%E8%B4%AD%E5%8D%8E%E7%BA%B3_%E6%B8%B8%E6%88%8F%E5%B7%A5%E4%BD%9C%E5%AE%A4%E4%B9%9F%E6%8B%BF%E5%88%B0%E6%89%8B/>网飞官宣827亿美元收购华纳 游戏工作室也拿到手</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/duty/>Duty</a></li><li class=widget__item><a class=widget__link href=../../../categories/duty2/>Duty2</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/cnbeta/ title=Cnbeta>Cnbeta (175)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/datawhale/ title=Datawhale>Datawhale (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/drpei/ title=Drpei>Drpei (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/fetched/ title=Fetched>Fetched (819)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/githubdaily/ title=GitHubDaily>GitHubDaily (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%B8%81%E9%A6%99%E5%9B%AD/ title=丁香园>丁香园 (30)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%BA%BA%E7%89%A9/ title=人物>人物 (16)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%8D%97%E6%96%B9%E5%91%A8%E6%9C%AB/ title=南方周末>南方周末 (12)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E4%BC%97%E8%BD%AF%E4%BB%B6/ title=小众软件>小众软件 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E5%A4%A7%E5%A4%AB%E6%BC%AB%E7%94%BB/ title=小大夫漫画>小大夫漫画 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%91%E6%95%B0%E6%B4%BE/ title=少数派>少数派 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%BE%AA%E5%9B%A0%E7%BC%89%E8%8D%AF/ title=循因缉药>循因缉药 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%96%B0%E4%B9%A1%E5%9C%9F/ title=新乡土>新乡土 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%98%9F%E7%90%83%E5%95%86%E4%B8%9A%E8%AF%84%E8%AE%BA/ title=星球商业评论>星球商业评论 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%88%E5%85%89%E5%8D%9A%E5%AE%A2/ title=月光博客>月光博客 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%AA%E9%97%BBcode/ title=未闻Code>未闻Code (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%A7%BD%E8%BE%B9%E5%BE%80%E4%BA%8B/ title=槽边往事>槽边往事 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%AF%8F%E6%97%A5%E4%BA%BA%E7%89%A9/ title=每日人物>每日人物 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AA%E6%BD%AE%E5%B7%A5%E4%BD%9C%E5%AE%A4/ title=浪潮工作室>浪潮工作室 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AE%E4%B9%8B%E9%9D%99/ title=浮之静>浮之静 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%81%BC%E8%A7%81/ title=灼见>灼见 (8)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%86%8A%E8%A8%80%E7%86%8A%E8%AF%AD/ title=熊言熊语>熊言熊语 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E6%8A%80%E8%83%BD%E6%A0%91/ title=生信技能树>生信技能树 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E8%8F%9C%E9%B8%9F%E5%9B%A2/ title=生信菜鸟团>生信菜鸟团 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90/ title=知识分子>知识分子 (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%BD%91%E6%98%93%E6%95%B0%E8%AF%BB/ title=网易数读>网易数读 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E6%96%B0/ title=财新>财新 (8)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E7%BB%8F%E4%B8%89%E5%88%86%E9%92%9F/ title=财经三分钟>财经三分钟 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B5%9B%E5%85%88%E7%94%9F/ title=赛先生>赛先生 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E9%83%91%E5%B7%9E%E6%A5%BC%E5%B8%82/ title=郑州楼市>郑州楼市 (33)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 文字轨迹.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>